Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Articles

Ralph G. Neas, president and CEO of the Generic Pharmaceutical Association, requests that Congress get involved in the support of a more competitive drug market.

GPhA Issues Statement on Generic Drug Costs

Although the source of spots and specks on tablets is sometimes difficult to identify, following good maintenance and manufacturing practices can help solve or even prevent the problem.

Eliminating Tablet Spots and Specks

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

A new report from The Pharmaceutical Care Management Association alleges that FDA hinders competition in the pharmaceutical industry and influences how a drug's price is calculated.

FDA Practices Discourage Biologic Market Competition, Says PCMA White Paper

Pfizer will pay $850 million upfront and as much as $2 billion later in a deal to jointly develop one of Merck?s cancer drugs.

Pfizer and Merck KGaA Announce Strategic Alliance

Grand River Aseptic Manufacturing has announced that the company executed two commercial production contracts in one day.

Grand River Aseptic Manufacturing Secures Two Contracts

Avastin plus chemotherapy for the treatment of ovarian cancer increased progression-free survival by 62% compared with chemotherapy alone.

Roche's Avastin Gains Ovarian Cancer Indication

After being plagued by numerous delays, Lemtrada (alemtuzumab) has finally been approved by FDA for the treatment of multiple sclerosis.

FDA Approves Lemtrada for the Treatment of Multiple Sclerosis

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Advanced analytical methods are speeding up the targeted evaluation of potential viral contaminants.

The Challenge of Finding the Unknown

Andy Dumelow is PharmaCare manager at I Holland.

Carrying on from our weekly column to help you eliminate a number of tablet manufacturing problems and tablet tooling failures with a simple seven-step tool-care process, we look at the third step, Repair.

Seven Steps to Solving Tabletting and Tooling Problems---Step 3: Repair

Catalent has acquired Micron Technologies, a provider of particle size engineering technologies.